Introduction: Inflammation of the prostate can be a cause of elevated prostate-specific antigen (PSA) in men referred for suspected prostate cancer. This systematic review assesses the evidence for antibiotic therapy in patients with type IV (asymptomatic) prostatitis with regard to reduction of PSA levels and discrimination between prostate cancer and inflammation. Methods: MEDLINE, EMBASE, and the Cochrane registry were searched for papers reporting on cohorts of men with elevated PSA and type IV prostatitis that were treated with antibiotics. Results: The search yielded 160 papers, of which 11 met the inclusion criteria: two randomized trials and nine cohort studies. In total, the studies reported on 1011 patients with type IV prostatitis, of whom 926 were treated with antibiotics. PSA normalization was seen after antibiotic treatment in 33.2% of patients (95% confidence interval [CI] 24.9-42.8). Meta-analysis of the randomized trials did not demonstrate a higher likelihood of PSA normalization in the antibiotics arm as compared to the control arm (odds ratio [OR] 1.27; 95% CI 0.58-2.76; p=0.553). Four studies performed prostate biopsies in all patients. Although three of these studies demonstrated lower prevalence of prostate cancer in patients in whom PSA had normalized, meta-analysis failed to show a statistically significant difference (OR 0.39; 95% CI 0.06-2.49; p=0.319).
Introduction
Inflammation of the prostate can be a cause of an elevated prostate specific antigen (PSA) in men referred for suspected prostate cancer. In the presence of symptoms of acute bacterial prostatitis or recurrent urinary tract infections, antibiotic therapy is clearly indicated. There is, however, a group of patients with inflammation of the prostate without symptoms or urinary tract infections: NIH Type IV prostatitis. 1 The European Association of Urology (EAU)
Guidelines for Urological Infections present antibiotics as an effective method to lower PSA in men with type IV prostatitis, 2 citing a single paper. 3 It remains unclear whether other studies support this practice. Several randomized trials have allocated all asymptomatic men with an elevated PSA to a course of antimicrobial therapy. These trials were summarized by Yang et al in 2015. 4 Their meta-analysis demonstrated that there was no difference in the proportion of patients with responsive PSA. Furthermore, patients with responsive PSA in the antibiotics group were not less likely to have prostate cancer than those with spontaneously decreased PSA in the control group.
Abovementioned studies, by design, included a large number of men without prostatitis. Therefore, a positive effect of antibiotics in men with type IV prostatitis may have been obscured. A number of investigators have assessed the effect of antibiotics specifically in patients with leucocytosis in expressed prostate secretion (EPS), post prostate massage voided urine (VB3) or histologically proven asymptomatic prostatitis.
The aim of this study was to systematically review the evidence for antibiotic therapy in patients with type IV prostatitis with regard to reduction of PSA levels and discrimination between prostate cancer and inflammation only.
Methods

Search strategy
A systematic literature search was conducted of the Medline, EMBASE and Cochrane Clinical Trials database up to 20-04-2016 . Results were limited to English language papers. Medline and EMBASE were searched using the following query:
-Prostatitis OR prostate inflammation -AND prostate specific antigen OR PSA -AND antibiotic OR antibiotics OR anti-microbial Subsequently, the reference lists of the included papers were searched for any further relevant articles.
As part of the publication bias analysis, the International Clinical Trials Registry Platform (ICTRP) was searched for any relevant trials.
Inclusion criteria
Articles were identified that reported on a cohort of men with NIH type IV prostatitis (confirmed either by laboratory results or histopathology results) that was treated with any form of antibiotics. Papers were included if they reported follow-up PSA levels and/or outcome of prostate biopsy after treatment with antibiotics.
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Outcome parameters
1. Decrease in PSA in patients who were or were not treated with antibiotics 2. Outcome of prostate biopsy in patients who had or had not exhibited a decline in PSA level
Data extraction and statistical analysis
Data were extracted from the selected studies by two of the authors independently (KTB and MM). When necessary, differences in interpretation were resolved by a third author (RP). Statistical analysis was performed in R 5 . Meta-analysis was performed. Calculation of effect sizes with 95% confidence intervals was accomplished by using inverse variance weighting. Between-study heterogeneity was assessed with the χ 2 test for heterogeneity. Data with significant heterogeneity (<5%) were pooled using a random-effects model, data without significant heterogeneity were pooled using a fixed effects model. 6 Forest plots were generated for graphical presentation of the outcomes. Funnel plots to assess for study bias were not deemed useful as the number of studies in each analysis was too small.
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Quality of studies was assessed using the NHLBI tool for Quality Assessment of Observational Cohort and Cross-sectional Studies and Quality Assessment of Controlled Intervention Studies where applicable.
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Results
Search
The primary search yielded 160 papers. After examining titles and abstracts 130 papers could be excluded (for inclusion flow-chart see Supplementary Figure 1 ). Full texts of the remaining 30 papers were examined. A further 19 were excluded for not meeting the inclusion criteria (17 papers) or because only abstracts were published of the studies (two papers). Examination of the reference lists of the eleven included papers 3,9-18 did not yield further studies that met the inclusion criteria. The search of the International Clinical Trials Registry Platform did not reveal any studies that met the inclusion criteria.
Study characteristics
Study characteristics are shown in Table 1 . Two studies were randomized controlled trials that assessed the effect of antibiotics versus placebo or no treatment in men with type IV prostatitis. 16, 18 The rest were prospective or retrospective cohort studies without a control group. Most studies diagnosed type IV prostatitis by white blood cell (WBC) count in EPS or VB3; one investigated patients with histologically proven type IV prostatitis upon biopsy.
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Fluoroquinolones were given in all but one study; 15 duration of treatment ranged between 2 to 8 weeks. In total, the studies reported on 1011 patients with type IV prostatitis of whom 926 were treated with antibiotics.
Quality of studies
Quality of studies was assessed using aforementioned NHLBI tools. Most cohort studies were rated 'Good Quality'; 9-15 two were rated 'Fair Quality'. 3, 17 The two randomized controlled trials were rated as 'Good Quality' 16 and 'Fair Quality'.
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Decrease in PSA Initial and final PSA levels were reported in seven studies (see Table 2 ). In the antibiotics group, the mean PSA decreased in all studies, with mean decrease ranging from 1.2 to 3.6ng/mL. The only study to report on PSA levels in the control group found a decrease in PSA from 5.2 to 4.0 ng/mL in the antibiotics group (levofloxacin 500mg once daily for 4 weeks) and no decrease in the control group (p = <0.001). 18 The proportion of patients with normalisation of PSA levels was reported by all but one study. The pooled average percentage of patients with normalised PSA after antibiotic treatment was 33.2% (95%-CI 24.9-42.8%).
A pooled analysis of the two randomized trials 16, 18 yielded an OR for normalisation of PSA of 1.27 (95%-CI 0.58 -2.76, p = 0.553) (see Figure 1a) .
Result of prostate biopsies
Outcome of prostate biopsies in all patients was reported in four studies (see Supplemmentary Table 1 ). Three of these studies reported a lower incidence of prostate cancer in patients in whom PSA had normalized compared to patients in whom PSA had not normalized. However, in meta-analysis, this effect did not reach statistical significance (OR 0.39; 95%-CI 0.06 -2.49, p = 0.319) (see Figure 1b) .
Discussion
This is the first systematic review to assess the effect of antibiotics specifically in men with type IV prostatitis. In all the included studies men treated with antibiotics exhibited a decrease in PSA. However, lack of control groups in most studies makes it impossible to conclude that this decrease in PSA can be attributed to antibiotics. Meta-analysis of the available randomised trials did not demonstrate superiority of antibiotic treatment above no treatment for normalisation of PSA. Previous meta-analysis focused upon antibiotic treatment of all men with elevated PSA 4 . No significant difference could be demonstrated between the antibiotic group and the control group in terms of normalisation of PSA. The current systematic review addresses the same question in men with biochemically or histologically proven inflammation of the prostate. This review focuses solely on men with asymptomatic (type IV) prostatitis. However, none of the included studies administered a standardized questionnaire (such as the NIHchronic prostatitis symptom index) to rule out a type III prostatitis. In most papers, clinical assessment including DRE was used to qualify patients as asymptomatic. As such the patient group may have been confounded by men with unrecognized chronic prostatitis type III.
As most studies in this systematic review did not include a control group, it is possible that other factors than the antibiotic therapy may have played a role in the decrease in PSA. One such factor could be natural fluctuation. 19 Theoretically, men who are referred for evaluation when their PSA is at a high point in their natural fluctuation will show regression to the mean in course of time.
CUAJ -Original Research Buddingh et al: Antibiotics and PSA levels
In order for antibiotics to have an effect on prostate inflammation, bacterial microorganisms have to play an active role in the inflammation. Most studies in this systematic review do not report routine cultures of EPS or VB3 urine. Karazanashvili et al report 15% positive culture rate. Kaygisiz et al found 20% positive cultures. 11 Potts et al report 36%
positive cultures. 15 It could be hypothesized that any effect of antibiotics would be limited to the subgroup of patients with positive cultures. However, Potts et al found that positive culture was not a predictor of response to antibiotics. Different types of histological prostatic inflammation have been described and a consensus classification was published in 2001. 20 The system grades inflammation by anatomical location (glandular, periglandular or stromal), extent (focal, multifocal or diffuse) and grade (mild, moderate or severe). It remains to be seen whether the proposed classification corresponds with outcome in terms of symptoms or PSA. Correlation between positive EPS and histological prostatitis is reported to be fair to poor. 11,13 Whether data of EPS-proven prostatic inflammation and biopsy-proven prostatitis should be combined may therefore be subject of debate. Inflammation upon first biopsy reduces the odds of prostate cancer in repeat biopsies, 21 presumably reflecting an elevated PSA as a result of inflammation. Only one of the included studies included men based upon biopsy results; therefore the outcome of this review mainly reflects findings in men with EPS-proven prostatitis. Any systematic review is limited by the quality of the available studies. The most important limitation is that most studies were retrospective and did not include a control group (i.e. men with type IV prostatitis that were treated with placebo or no treatment). Two of the papers found in the initial search were excluded as they were published as conference abstracts only. The quality of abstracts cannot be assessed in the same way as that of full publications. Many abstracts do not progress to full publications; in the studies that are published there may /be substantial abstract-to-publication discordance in data. 22 Publication bias, if present in this review, is likely to favour studies that show a positive effect of antibiotics on PSA. This could be the reason why most cohort studies report substantially higher rates of PSA normalisation than the randomized trials. A search of the International Clinical Trials Registry Platform revealed no non-published studies that met the inclusion criteria and thus no further evidence of publication bias. A formal assessment by means of funnel plot was deemed inappropriate because of too few studies 7 .
Any beneficial effect of antibiotics, or lack thereof, should be weighed against the possible side effects of prolonged therapy with quinolones. Although they are generally well tolerated, side effects range from frequent and mild such as diarrhoea and vomiting, to rare but severe such as tendon ruptures and arrhythmia 23 . Furthermore, resistance to oral antibiotics, especially fluoroquinolones is an important factor leading to post prostate biopsy sepsis. 24 The European Association of Urology Guidelines on Urological Infections 2 recommend the use of antibiotics in patients with evidence of prostatic inflammation, referring to the paper by Bozeman et al. 3 It is apparent from this review that this may be an oversimplification of the clinical problem and that this recommendation may need to be nuanced. Fig. 1A . Meta-analysis of two randomized trials. Odds ratio (OR) of normalization of prostate-specific antigen. Left favours control group; right favours antibiotics. CI: confidence interval. 
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